Pharma Journalist -

Novartis proclaimed a licensing agreement with Spark Therapeutics encompassing development, registration and commercialization rights to voretigene neparvovec in markets outside the US.…
Read More...

With a view to addressing a $1.8 billion market globally, and a European market estimated to exceed $500 million, TechCare Corporation a technology company with a revolutionary delivery…
Read More...

Developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, TECHLAB sought U.S FDA's clearance for the CAMPYLOBACTER QUIK CHEK and the CAMPYLOBACTER…
Read More...

The company focused on the development of Conditionally Active Biologic (CAB) protein therapeutics, BioAtla asserted that the U.S FDA has cleared Investigational New Drug application…
Read More...

Leading provider of clinical trial support services, Paragon International affirmed new name "Paragon Global CRS" The name symbolizes the variety of services currently being offered by…
Read More...

Perrigo Company sought U.S FDA's approval for the launch of generic version of Epiduo (adapalene and benzoyl peroxide) Gel, 0.1%/2.5%. Perrigo Executive Vice President and President…
Read More...

U.S Food and Drug Administration approved Perrigo Company's generic version of Estrace Cream anticipated to be launched in the second quarter of the year. Constituents of the cream are…
Read More...

Spectris plc acquires Concept Life Sciences, the integrated drug discovery, development and analytical services and environmental consultancy company. Spectris has acquired the Concept…
Read More...

Late-stage clinical biopharmaceutical company, Liquidia Technologies focused on enhancing the performance of medicine by precisely engineering drug particles, today announced positive…
Read More...

Pixium Vision, Company committed to curating bionic vision systems ensuring revival of lost sight to patients, asserted the world’s first successful human implantation and activation of…
Read More...